Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Increased vitamin D levels at birth and in early infancy increase offspring allergy risk-evidence for involvement of epigenetic mechanisms.

Junge KM, Bauer T, Geissler S, Hirche F, Thürmann L, Bauer M, Trump S, Bieg M, Weichenhan D, Gu L, Mallm JP, Ishaque N, Mücke O, Röder S, Herberth G, Diez U, Borte M, Rippe K, Plass C, Hermann C, Stangl GI, Eils R, Lehmann I.

J Allergy Clin Immunol. 2015 Aug 15. pii: S0091-6749(15)00941-0. doi: 10.1016/j.jaci.2015.06.040. [Epub ahead of print] No abstract available.

PMID:
26282283
2.

Pathway and time-resolved benzo[a]pyrene toxicity on Hepa1c1c7 cells at toxic and subtoxic exposure.

Kalkhof S, Dautel F, Loguercio S, Baumann S, Trump S, Jungnickel H, Otto W, Rudzok S, Potratz S, Luch A, Lehmann I, Beyer A, von Bergen M.

J Proteome Res. 2015 Jan 2;14(1):164-82. doi: 10.1021/pr500957t. Epub 2014 Nov 17.

PMID:
25362887
3.

Live cell imaging of the intracellular compartmentalization of the contaminate benzo[a]pyrene.

Ali R, Trump S, Lehmann I, Hanke T.

J Biophotonics. 2015 May;8(5):361-71. doi: 10.1002/jbio.201300170. Epub 2014 Apr 3.

PMID:
24700684
4.

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.

Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, Winter M, Ott M, Ochs K, Lutz C, Liu X, Anastasov N, Lehmann I, Höfer T, von Deimling A, Wick W, Platten M.

Oncotarget. 2014 Feb 28;5(4):1038-51.

5.

Parameter importance in FRAP acquisition and analysis: a simulation approach.

Mai J, Trump S, Lehmann I, Attinger S.

Biophys J. 2013 May 7;104(9):2089-97. doi: 10.1016/j.bpj.2013.03.036.

6.

Benzo[a]pyrene affects Jurkat T cells in the activated state via the antioxidant response element dependent Nrf2 pathway leading to decreased IL-2 secretion and redirecting glutamine metabolism.

Murugaiyan J, Rockstroh M, Wagner J, Baumann S, Schorsch K, Trump S, Lehmann I, Bergen Mv, Tomm JM.

Toxicol Appl Pharmacol. 2013 Jun 15;269(3):307-16. doi: 10.1016/j.taap.2013.03.032. Epub 2013 Apr 10.

PMID:
23583300
7.

Inhibition of endotoxin-induced perinatal asthma protection by pollutants in an experimental mouse model.

Reiprich M, Rudzok S, Schütze N, Simon JC, Lehmann I, Trump S, Polte T.

Allergy. 2013 Apr;68(4):481-9. doi: 10.1111/all.12121. Epub 2013 Feb 15.

PMID:
23409786
8.

Transcriptional signatures of regulatory and toxic responses to benzo-[a]-pyrene exposure.

Michaelson JJ, Trump S, Rudzok S, Gräbsch C, Madureira DJ, Dautel F, Mai J, Attinger S, Schirmer K, von Bergen M, Lehmann I, Beyer A.

BMC Genomics. 2011 Oct 13;12:502. doi: 10.1186/1471-2164-12-502.

9.

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M.

Nature. 2011 Oct 5;478(7368):197-203. doi: 10.1038/nature10491.

PMID:
21976023
10.

Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.

Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, Miranda TB, Sung MH, Trump S, Lightman SL, Vinson C, Stamatoyannopoulos JA, Hager GL.

Mol Cell. 2011 Jul 8;43(1):145-55. doi: 10.1016/j.molcel.2011.06.016.

11.

T-2 toxin is a cytochrome P450 1A1 inducer and leads to MAPK/p38- but not aryl hydrocarbon receptor-dependent interleukin-8 secretion in the human intestinal epithelial cell line Caco-2.

Kruber P, Trump S, Behrens J, Lehmann I.

Toxicology. 2011 Jun 18;284(1-3):34-41. doi: 10.1016/j.tox.2011.03.012. Epub 2011 Mar 29.

PMID:
21453744
12.

Are assumptions about the model type necessary in reaction-diffusion modeling? A FRAP application.

Mai J, Trump S, Ali R, Schiltz RL, Hager G, Hanke T, Lehmann I, Attinger S.

Biophys J. 2011 Mar 2;100(5):1178-88. doi: 10.1016/j.bpj.2011.01.041.

13.

DIGE-based protein expression analysis of B[a]P-exposed hepatoma cells reveals a complex stress response including alterations in oxidative stress, cell cycle control, and cytoskeleton motility at toxic and subacute concentrations.

Dautel F, Kalkhof S, Trump S, Michaelson J, Beyer A, Lehmann I, von Bergen M.

J Proteome Res. 2011 Feb 4;10(2):379-93. doi: 10.1021/pr100723d. Epub 2010 Dec 21.

PMID:
21171653
14.

Recurrent metabolic acidosis in a dialysis patient.

Elitok S, Trump S, Hampl H, Leibfritz D, Kettritz R, Luft FC.

Kidney Int. 2010 Aug;78(4):425-6. doi: 10.1038/ki.2010.180. No abstract available.

PMID:
20671736
15.

Kinetic complexity of the global response to glucocorticoid receptor action.

John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer PS, Hager GL.

Endocrinology. 2009 Apr;150(4):1766-74. doi: 10.1210/en.2008-0863. Epub 2009 Jan 8.

16.

Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension.

Laudi S, Steudel W, Jonscher K, Schöning W, Schniedewind B, Kaisers U, Christians U, Trump S.

Proteomics. 2007 Jul;7(14):2469-78.

PMID:
17623304
17.

Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.

Laudi S, Trump S, Schmitz V, West J, McMurtry IF, Mutlak H, Christians U, Weimann J, Kaisers U, Steudel W.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L630-8. Epub 2007 Jun 15.

18.

Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine.

Laudi S, Weimann J, Haschke M, Trump S, Schmitz V, Christians U, Kaisers U, Steudel W.

J Physiol Pharmacol. 2007 Mar;58(1):19-32.

19.

1H-NMR metabolic profiling of human neonatal urine.

Trump S, Laudi S, Unruh N, Goelz R, Leibfritz D.

MAGMA. 2006 Dec;19(6):305-12. Epub 2006 Nov 29.

PMID:
17136356
20.

Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics.

Christians U, Strom T, Zhang YL, Steudel W, Schmitz V, Trump S, Haschke M.

Ther Drug Monit. 2006 Feb;28(1):39-44. Review.

PMID:
16418692
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk